1073154-85-4
1073154-85-4
Chemical Structure
Defactinib
Synonym(s): VS-6063; PF-04554878
- CAS No.: 1073154-85-4
- Formula:C20H21F3N8O3S
- Molecular Weight:510.49
IUPAC Name: N-methyl-4-((4-(((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide
InChIKey: FWLMVFUGMHIOAA-UHFFFAOYSA-N
SMILES: O=C(NC)C1=CC=C(NC2=NC=C(C(F)(F)F)C(NCC3=NC=CN=C3N(C)S(=O)(C)=O)=N2)C=C1
Biological Activity: Defactinib (VS-6063; PF-04554878) is a novel FAK inhibitor with potential antiangiogenic and antineoplastic activities.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Defactinib | 99.74% | Defactinib (VS-6063; PF-04554878) is a novel FAK inhibitor with potential antiangiogenic and antineoplastic activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Defactinib (Standard) | ≥98% | Defactinib (Standard) is the analytical standard of Defactinib. This product is intended for research and analytical applications. Defactinib (VS-6063; PF-04554878) is a novel FAK inhibitor with potential antiangiogenic and antineoplastic activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Defactinib-d6 | Defactinib-d6 is a deuterium labeled Defactinib (HY-12289). Defactinib is a novel FAK inhibitor with potential antiangiogenic and antineoplastic activities. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
